PATIENT SAFETY


medication more rapidly speeding up clinical pathways and procedures, especially in emergency setting.11


Safety-engineered


pre-filled devices specifically enable ease and accuracy of drug delivery in healthcare organisations as well as in the home. Reports12


indicate a clear dominance of


safety-engineered pre-filled syringes, suggesting that pharmaceutical and biotechnology firms are particularly concerned with offering their users safety features – regardless of the environment of administration; the home, or the hospital. Safety elements are therefore being favoured in production of combination products, and thought to provide brand advantage in face of numerous requirements by patients, healthcare users and regulatory authorities. In particular, our recent report13


As a number of originalbiologics come out of patent protection, a hostof newdrugs are entering a newly competitive market reducing cost to patients and encouraging self-administration.


highlights


some of the major drivers for the increasing demand for safety-engineered devices as better regulatory compliance; higher standards of protection of healthcare workers – whether they are practicing within a clinical setting or in the home of outpatients; protection of users form accidental injury and medical error; adequate response to pressures on healthcare systems to improve efficiency that encourage greater patient self-administration; the drive towards regular self-administration fuelled by new biological therapies and competitive biosimilar markets and increased demand of easy-to-use injectable therapies resulting from ageing populations.


As safety device demand continues to grow across the globe driven by these various factors, pre-filled syringes are also increasingly in demand to improve dosage accuracy. As a result, the market leading category combines both aspects-pre-filled safety-engineered devices that respond to the various needs of users requiring safety mechanisms, sharps protection, accurate dosage and high usability for infirm patients.


References


1 Market Data Forecast, Safety Syringes Market by Technology, Oct 2018


2 Tatelbaum MF, Needlestick safety and prevention act, Pain Physician. 2001 Apr;4(2):193-5.


3 Medical Devices:Evidence and Research, Vol 10, Clinical, economic, and humanistic burden of needlestick injuries in healthcare workers, 2 May 2017


4 Montana State University, Proportion of Registered Nurses Employed in Hospitals Falls Below 60% in 2013, May 2014


5 Bureau of Labor Statistics: Employment Projections: Fastest growing occupations. U.S. Department of Labor. http://www.bls.gov/emp/ep_table_103.htm (2013).


6 Risk of sharps injuries among home care aides: Results of the Safe Home Care survey. Brouillette NM, Quinn MM, Kriebel D, Markkanen PK, Galligan CJ Sama SR, Gore RJ, Laramie AK, Davis L Am J Infect Control. 2017 Apr 1; 45(4):377-383.


7 European Biosafety Network, Sharps Safety Survey 2016


CSJ


8 See, for instance: The Lancet, Ageing: a 21st century public health challenge? July 2017; The Kings Fund, Making our health and care systems fit for an ageing population, Mar 2014


9 Global Biosimilar Pipeline and Market Prospects. Adam Bradbury and Rishikesh Mandilwar, GBI Research, 2017


10 See, for instance: The Telegraph, NHS drug errors may be causing up to 22,000 deaths every year, 23 Feb 2018


11 As an example: BMJ Simulation & Technology Enhanced Learning, Intubation drug pack containing pre-filled syringes reduces the time to endotracheal intubation in a simulated paediatric emergency, 23 Feb 2018


12 Market Data Forecast, Safety Syringes Market by Technology, Oct 2018


13 Owen Mumford Pharmaceutical Services, Safety First, September 2019


Why Become A Member?


CENTRAL STERILISING CLUB THE ORIGINAL DECONTAMINATION FORUM


ESTABLISHED IN 1960


The CSC welcomes all individuals involved in decontamination and infection prevention to join, offering a large range of networking opportunities and support.


Join us


The CSC has a wide membership from across the UK and from all disciplines involved in decontamination and infection prevention.


Personal Membership


Personal memberships possess full voting rights.


Annual Fee £20


Corporate Membership


Membership for commercial companies but possesses no voting rights.


Annual Fee £90 NOVEMBER 2019


One of the oldest infection prevention societies in Europe. The Central Sterilising Club was founded in 1960 by a small group of enthusiastic individuals, working to address some of the most current healthcare sterilisation and decontamination challenges, with a membership that has world-class expertise and experience.


We provide the opportunity to voice concerns about decontamination and an advocate for improvement and best practice.


High quality cost effective educational events. Low-cost annual membership demonstrating excellent value for money.


Opportunity to apply for funding in support of undertaking research, training or attendance at CSC organised events via the Hurrell Simpson Award.


The only professional organisation with a truly multi-disciplinary membership where all members contribute to activities on an equal basis.


Visit us at: centralsterilsingclub.org/membership


WWW.CLINICALSERVICESJOURNAL.COM I


73


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104